CURLF · Curaleaf Holdings, Inc.
$8.34
-0.16 (-1.88%)
At close · Jul 29
Market Cap
$5.20B
Shares
623.52M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$8.34
Open$8.68
Day$8.25–8.85
52W$4.02–15.15
Avg vol 30d171K
Short int483K · 0.1% float · 1.6d
Short vol25%
Last earningsAug 5, 2026
DataJan 2020–Jul 2026
Up next
Next earnings call
Aug 5, 2026
Scheduled
· in 1 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Sell
Momentum
Strong
Sentiment
Bullish
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 20.7 · elevated
Equity put/call 0.61
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−2%
below
Price vs 50-day avg
−16%
below
RSI (14)
35
neutral
MACD trend
Negative
52-week position
39%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−23%
trailing
6-month return
+20%
trailing
YTD return
+10%
this year
Relative strength
+14%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $10 › 200d $9 — 50d above 200d
Institutional flow
Accumulating
3 of 6 funds reported for Jun 30 · net +7 sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.08% of float · ▼ -7.3% MoM · 1.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
6 holders — mid 3-yr range
Squeeze score
42
elevated · 0–100
Fundamentals
Revenue growth
−5%
Y/Y
Gross margin
50%
expanding
EPS growth
−9%
Y/Y
Free cash flow
$74.3M
Balance sheet
$385.5M
net debt
Quant / Vol
risk profile
Volatility
123%
annualized · 1-yr
Max drawdown
−60%
past year
ATR
7.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−2%
Neutral
Price vs 50-day avg
−16%
Bearish
RSI (14)
35
Neutral
MACD trend
Negative
Bearish
52-week position
39%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $10 › 200d $9 — 50d above 200d
Institutional flow
Accumulating
3 of 6 funds reported for Jun 30 · net +7 sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.08% of float · ▼ -7.3% MoM · 1.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
6 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $4
Now $8 · 39%
52-wk high $15
vs 200-day avg -2%
vs 50-day avg -16%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CURLF
this stock
Curaleaf Holdings, Inc.
|
$5.20B | +10.3% | -0.9% | — | 0.1% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$55.95B | +13.9% | — | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$50.49B | +4.2% | — | — | 0.0% |
|
HLN
Haleon plc
|
$45.23B | +1.7% | — | — | 0.3% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CURLF | -11.0% | -22.9% | +19.8% | -22.9% | +10.3% |
| SPY | -2.4% | -2.3% | +6.3% | -2.3% | +7.0% |
| vs SPY | -8.6% | -20.5% | +13.5% | -20.5% | +3.4% |